MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-02-0017300
Univeda Pharma Private Limited
Univeda Pharma Private Limited - non-profit organizations in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.23 Lakh
▼ 6% YoY
Net loss · FY 2025
₹7.87 Lakh
Net margin -28.9%
EBITDA · FY 2025
-₹7.67 Lakh
EBITDA margin -28.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.2 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Univeda Pharma Private Limited
Data last updated:
Univeda Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 18 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85300DL2021PTC381242. Its GSTIN is 07AACCU8411A1ZR (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Fakhruddin Ahmed and Faizuddin.
Its last annual general meeting (AGM) was held on 18 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 38 – Apvt Flat No 8 2nd Floor, Main Road West Lakshmi Market Khureji Khas, New Delhi, Delhi, India – 110051.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.23 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹7.87 Lakh (net margin -28.9%) and EBITDA of -₹7.67 Lakh (EBITDA margin -28.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
Univeda Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0017300).
Company details
CIN U85300DL2021PTC381242
Registration Number 381242
Incorporation Date 18 May 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 August 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0017300
Recognitions & Rankings of Univeda Pharma
Contact details
Univeda Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address38 – Apvt Flat No 8 2nd Floor, Main Road West Lakshmi Market Khureji Khas, New Delhi, Delhi, India – 110051
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Univeda Pharma Private Limited, buy the company report.
Comprehensive company report
Univeda Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Univeda Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Univeda Pharma Private Limited, buy the company report.
Financials of Univeda Pharma Private Limited
FY 2025 filings availableUniveda Pharma Private Limited reported revenue of ₹27.23 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹27.23 Lakh ▼ 6%
Net loss · FY 2025
₹7.87 Lakh margin -28.9%
EBITDA · FY 2025
-₹7.67 Lakh margin -28.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 42%
3 years · compounded
▼ 29%
Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹7.67 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹7.87 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -28.2% | |||
| Net Profit Margin | -28.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Univeda Pharma Private Limited, buy the company report.
Board of directors of Univeda Pharma Private Limited
Univeda Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fakhruddin Ahmed Also directs: Webtech Electronics Private Limited, Kandhlavi Traders Private Limited, Webmark India Infotech Private Limited and 1 more | Director | 18 May 2021 | 5 Years 5 Months | Current |
| Faizuddin Also directs: Webtech Electronics Private Limited, Webmark India Infotech Private Limited, Skyshine Media Private Limited and 1 more | Additional Director | 27 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Univeda Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mind Touch Counsellors Private Limited | ₹27.39 Lakh (FY 2025) | 53.0% | Kanayannur, Kerala, India | |||
| Priyanshi Dent Designs Solution Private Limited | ₹27.37 Lakh (FY 2025) | 131.0% | Delhi, India | |||
| Avartan Dance Foundation | ₹27.37 Lakh (FY 2025) | 175.0% | Pune, Maharashtra, India | |||
| Sunaina Opticians Private Limited | ₹27.34 Lakh (FY 2025) | 478.0% | Bengaluru, Karnataka, India | |||
| Jaipur Laser Vision Centre Private Limited | ₹27.29 Lakh (FY 2025) | -41.0% | Jaipur, Rajasthan, India | |||
| Univeda Pharma Private Limitedthis company | ₹27.23 Lakh (FY 2025) | -₹7.87 Lakh | -28.9% | -6.0% | New Delhi, Delhi, India | |
| Laszlo International Private Limited | ₹27.2 Lakh (FY 2025) | 30.0% | Bangalore, Karnataka, India | |||
| KP International Health Solutions Private Limited | ₹27.16 Lakh (FY 2024) | -3.0% | Hansi, Haryana, India | |||
| Ostara Health Care Private Limited | ₹27.12 Lakh (FY 2025) | -70.0% | Hisar, Haryana, India | |||
| Care & Ease Healthcare (OPC) Private Limited | ₹27.04 Lakh (FY 2025) | 1.0% | Miraroad East Thane, Maharashtra, India | |||
| Brahmapuri Life Essentials Spiritual and Research Foundation | ₹26.94 Lakh (FY 2025) | -13.0% | Satara, Maharashtra, India |
To see the full peer comparison of Univeda Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Univeda Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Univeda Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Univeda Pharma Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
Active EPFO establishments
1
GST
Univeda Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCU8411A1ZR | Delhi | Active | 23 Jun 2021 |
| 09AACCU8411A1ZN | Uttar Pradesh | Active | 03 Jun 2021 |
To see the full GST registrations and return filing status of Univeda Pharma Private Limited, buy the company report.
Recent activity
Univeda Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Faizuddin was appointed as Additional Director on 27 Mar 2025.
AGM
Univeda Pharma Private Limited last Annual general meeting of members was held on 18 Aug 2025 as per latest MCA records.
Filing
Univeda Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Faizuddin was appointed as Additional Director.
Ceased
Mohd Rashid Alam ceased to be Director.
Appointed
Fakhruddin Ahmed was appointed as Director.
Incorporation
18 May 2021
Univeda Pharma Private Limited was registered on 18 May 2021 with Roc Delhi & aged 5 years 5 months as per MCA records.
Frequently asked questions
Univeda Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 18 May 2021 (5+ years old) and is registered under CIN U85300DL2021PTC381242.
Univeda Pharma has 2 current directors:
- Fakhruddin Ahmed - Director
- Faizuddin - Additional Director
The latest financial statements of Univeda Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 August 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Univeda Pharma is 07AACCU8411A1ZR, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AACCU8411A1ZN (Uttar Pradesh).
The CIN (Corporate Identification Number) of Univeda Pharma is U85300DL2021PTC381242. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Univeda Pharma was incorporated on 18 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Univeda Pharma by revenue are Mind Touch Counsellors Private Limited, Priyanshi Dent Designs Solution Private Limited, Avartan Dance Foundation, Sunaina Opticians Private Limited, Jaipur Laser Vision Centre Private Limited and 5 more, all in the same principal business activity (human health activities).
Faizuddin was appointed as Additional Director on 27 Mar 2025. Mohd Rashid Alam ceased to be Director on 27 Mar 2025. Fakhruddin Ahmed was appointed as Director on 18 May 2021.
Yes, Univeda Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0017300).
The registered office of Univeda Pharma is at 38 – Apvt Flat No 8 2nd Floor, Main Road West Lakshmi Market Khureji Khas, New Delhi, Delhi, India – 110051.
Univeda Pharma operates in the non-profit organizations industry, in the social work segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages